As a community oncologist, I enjoyed James DeGregori and Robert Gatenby’s article “Darwin’s Cancer Fix.” Their approach to treating metastatic prostate cancer by managing its growth, rather than trying to kill all cancer cells, to avoid drug-resistant tumors is intriguing and deserves a large randomized phase III trial. But it is very important to remember that, biologically, cancers are extremely heterogeneous, and there are caveats to the principles the authors outline.
Having trouble accessing this article? Please visit our FAQ page for more information
Expertise. Insights. Illumination.
Discover world-changing science. Explore our digital archive back to 1845, including articles by more than 150 Nobel Prize winners.